Related Experiment Videos
Vancomycin-induced neutropenia resolves after substitution with teicoplanin
S E Sanche1, W N Dust, Y M Shevchuk
1Division of Infectious Diseases, Royal University Hospital, Saskatoon, SK, Canada. sanche@duke.usask.ca
Summary
Neutropenia is a rare side effect of vancomycin. Replacing vancomycin with teicoplanin resolved neutropenia in a patient needing continued antibiotic treatment, offering a potential therapeutic option.
Area of Science:
- Pharmacology
- Hematology
- Infectious Diseases
Background:
- Neutropenia is an uncommon adverse effect of prolonged vancomycin therapy.
- Recovery of neutrophil counts typically occurs after vancomycin discontinuation.
- Alternative treatment strategies are needed for patients requiring ongoing antibiotic therapy.
Observation:
- A case of vancomycin-induced neutropenia was observed.
- The patient required continued antibiotic treatment.
Findings:
- Neutropenia resolved when vancomycin was replaced with teicoplanin.
- Teicoplanin, a structurally related compound, was used as an alternative.
Implications:
- Teicoplanin may be a viable treatment option for vancomycin-induced neutropenia.
- This finding offers a potential solution for patients needing ongoing therapy.
- Further research into teicoplanin's safety and efficacy in such cases is warranted.